Fangda Partners
Client SatisfactionWith a sizeable presence in Hong Kong as well as on the Mainland, Red Circle heavyweight law firm Fangda Partners provides ‘insightful and precise guidance’ to PRC issuers across a variety of fundamental ECM tasks, as well as in public M&A scenarios. The firm leverages its solid foundation in regulatory matters to ensure complex transactions are managed effectively and that listed clients receive continual compliance support as needed. Key to the firm’s success in the area is the work of corporate head Colin Law, who is appreciated for his ability to nurture long lasting client relationships and excels at providing ’practical and effective solutions’, including to Chinese biotech companies seeking to list on the HKEX.
Testimonials
Collated independently by Legal 500 research team.
- 'What sets the Fangda team apart is their seamless collaboration between senior and junior resources, ensuring a holistic approach to handling complex HKEX regulatory matters.'
- 'They are able to provide insightful and precise guidance.'
- 'Colin Law's reputation as a true problem solver is well-earned, as evidenced by his proactive approach to addressing client challenges and his commitment to delivering practical and effective solutions.'
- 'What sets Colin Law apart is not only his legal expertise but also his dedication to nurturing long-term client relationships. His engagement, timely response, and willingness to go above and beyond to support project requirements reflect his exceptional work ethic.’
Key clients
- WuXi XDC Cayman Inc.
- WuXi Biologics
- JW (Cayman) therapeutics Co. Ltd.
- Jinxin Fertility Group Limited
- CStone Pharmaceuticals
- Citigroup Global Markets Inc.
- Barclays Capital Asia Limited
- OrbiMed Advisor LLC
- Softbank Investment Advisers
- Haitong International Securities Group Limited
- Dongxing Securities (Hong Kong) Company Limited
- Guotai Junan Capital Limited
Lawyers
Practice head
The lawyer(s) leading their teams.
Colin Law